• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FIDIA FARMACEUTICI S.P.A. HYMOVIS; SODIUM HYALURONATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FIDIA FARMACEUTICI S.P.A. HYMOVIS; SODIUM HYALURONATE Back to Search Results
Lot Number F35910
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Hot Flashes/Flushes (2153)
Event Date 03/24/2023
Event Type  Injury  
Event Description
This is a case-report received by fidia from an italian specialist physician (orthopedic) on (b)(6) 2023.Initially this case has been assessed by the primary reporter (physician) as a non-serious case-report.According to the follow-up information received on 17 may 2023, the case-report has been updated as serious case-report, because of other medically important condition: continuing discomforts (local feeling of body temperature changes) for about 2 months.On (b)(6) 2023, two injections of hymovis (batch number: f35910) were administered to a 75-year-old male patient to both knees, for arthrosis.Relevant medical history included: arthrosis.On (b)(6) 2023, the patient experienced a sensation of coldness local (in the knees), hot feeling in feet and hot flushes of legs.As a result of these undesirable side-effects, the patient wakes up several times during the night.As a result of the undesirable side-effect experienced, the patients went to his general practitioner who prescribed him nsaids, corticosteroids therapy and the laboratory tests (emg, mri, ultrasound doppler), as in his opinion the device had not administered correctly (outside the intra-articular space).On (b)(6) 2023, the patient informed the orthopedic (primary reporter) about the undesirable side-effects experienced; on the same date, fidia received this case-report from the orthopedic.Up to (b)(6) 2023, the orthopedic informed fidia that the outcome of the occurred undesirable side-effects was not resolved, and that the results of the laboratory tests were negative.Reactions as reported by primary reporter: "cold knee, hot feet and heat in the legs (bilateral).Difficulty sleeping due to discomfort".Concomitant medication was not reported.On 25 may 2023, the investigation results on batch analysis received by fidia manufacturing quality department pointed out that: no quality anomalies were detected from the investigation performed on the production and quality control documentation; so no relation can be associated with the reported incidents.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HYMOVIS
Type of Device
SODIUM HYALURONATE
Manufacturer (Section D)
FIDIA FARMACEUTICI S.P.A.
via ponte della fabbrica 3/a
abano terme, padua 35031
IT  35031
Manufacturer (Section G)
FIDIA FARMACEUTICI S.P.A.
via ponte della fabbrica 3/a
abano terme, padua 35031
IT   35031
Manufacturer Contact
giuseppina lo castro
via ponte della fabbrica 3/a
abano terme, padua 35031
IT   35031
MDR Report Key17036888
MDR Text Key316285528
Report Number9610200-2023-00003
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeIT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 05/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot NumberF35910
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/26/2023
Initial Date FDA Received06/01/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age75 YR
Patient SexMale
-
-